ASSET | DATE | % RETURN |
---|---|---|
Azitra (AZTR) | 6/1/2022 - 7/31/2023 | 2,019,542.86% |
Digital Brands (DBGIW) | 6/1/2022 - 7/31/2023 | 6,021.5% |
NewAmsterdam Pharma Company NV Warrant (NAMSW) | 6/1/2022 - 7/31/2023 | 1,950% |
Cabaletta Bio (CABA) | 6/1/2022 - 7/31/2023 | 964.06% |
MoonLake Immunotherapeutics (MLTX) | 6/1/2022 - 7/31/2023 | 806.26% |
Scilex (SCLXW) | 6/1/2022 - 7/31/2023 | 653.93% |
error (ZVZZT) | 6/1/2022 - 7/31/2023 | 634.83% |
Symbotic (SYM) | 6/1/2022 - 7/31/2023 | 568.14% |
Super Micro Computer (SMCI) | 6/1/2022 - 7/31/2023 | 552.97% |
Viking Therapeutics (VKTX) | 6/1/2022 - 7/31/2023 | 544.44% |
Avadel Pharmaceuticals (AVDL) | 6/1/2022 - 7/31/2023 | 526.67% |
Aehr Test Systems (AEHR) | 6/1/2022 - 7/31/2023 | 510.77% |
Ardelyx (ARDX) | 6/1/2022 - 7/31/2023 | 492.93% |
Reviva Pharmaceuticals (RVPHW) | 6/1/2022 - 7/31/2023 | 469.65% |
Nuvalent (NUVL) | 6/1/2022 - 7/31/2023 | 460.11% |
ENDRA Life Sciences (NDRA) | 6/1/2022 - 7/31/2023 | 440.1% |
Immunovant (IMVT) | 6/1/2022 - 7/31/2023 | 439.72% |
Indivior PLC Ordinary Shares (INDV) | 6/1/2022 - 7/31/2023 | 435.66% |
NioCorp Developments Ltd Common Stock (NB) | 6/1/2022 - 7/31/2023 | 432.13% |
89bio (ETNB) | 6/1/2022 - 7/31/2023 | 419.34% |
Rhythm Pharmaceuticals (RYTM) | 6/1/2022 - 7/31/2023 | 412.64% |
BridgeBio Pharma (BBIO) | 6/1/2022 - 7/31/2023 | 408.87% |
Akero Therapeutics (AKRO) | 6/1/2022 - 7/31/2023 | 402.61% |
US GoldMining Inc Warrant (USGOW) | 6/1/2022 - 7/31/2023 | 399.91% |
Limbach (LMB) | 6/1/2022 - 7/31/2023 | 391.08% |